AuStralian COVID Trial (ASCOT)
ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.
Related Broad Research Areas
- Anticoagulation strategies in non–critically ill patients with Covid-19
- Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
- Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: A structured, narrative review